Components of Metabolic Syndrome and the Rising Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States

被引：0
|
作者：
Stepanova, Maria
Afendy, Mariam
Vernon, Gregory C.
Nader, Fatema
Younossi, Zobair M.
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S988 / S988
页数：1
相关论文
共 50 条
  • [21] A Non-Invasive Prediction Model for Non-Alcoholic Steatohepatitis (NASH) in Pediatric Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Eng, Katharine
    Lopez, Rocio
    Nobili, Valerio
    Alkhouri, Naim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S114 - S115
  • [22] Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Verma, Siddharth
    Jensen, Donald
    Hart, John
    Mohanty, Smruti R.
    LIVER INTERNATIONAL, 2013, 33 (09) : 1398 - 1405
  • [23] FUNCTIONAL PATHWAY ANALYSIS OF GENE EXPRESSION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Stepanova, M.
    Manyam, G.
    Hossain, N.
    Chandhoke, V.
    Baranova, A.
    Goodman, Z.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S313 - S313
  • [24] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [25] Liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miette, Veronique
    Fournier, Celine
    Adara, Linda
    Sandrin, Laurent
    2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 1333 - 1336
  • [26] Metabolic syndrome (MS) in non-alcoholic fatty liver disease (NAFLD)
    Bugianesi, E
    Marchesini, G
    Manini, R
    Moscatiello, S
    Striuli, L
    Vanni, E
    Gentilcore, E
    Zanotti, E
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 191 - 191
  • [27] Predictive Value of ALT for Diagnosing Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
    Verma, Siddharth
    Sharma, Prashant
    Hart, John
    Mohanty, Smruti R.
    GASTROENTEROLOGY, 2012, 142 (05) : S1019 - S1020
  • [28] HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis
    Karrar, Azza
    Li, Zheng
    Moosvi, Ali M.
    Hariharan, Siddharth
    Fang, Yun
    Stepanova, Maria
    Goodman, Zachary D.
    Younossi, Zobair
    HEPATOLOGY, 2014, 60 : 601A - 602A
  • [29] Independent Predictors of Non-alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in a Large Cohort of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Fang, Yun
    Rafiq, Nila
    Afendy, Mariam
    Younossi, Youssef
    Lam, Brian
    Goodman, Zachary
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S120 - S120
  • [30] Melanocortins and Interleukins Contributing to Advanced Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in Patients With BMI ≥ 40
    Baranova, Ancha
    Jarrar, Mohammed
    Moazzez, Amir H.
    Elariny, Hazem
    Abawi, Massih
    Wang, Lei
    Afendy, Arian
    Stepanova, Maria
    Estep, J. M.
    Younossi, Zobair M.
    OBESITY, 2011, 19 : S87 - S87
12345